AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2017
Feb 21, 2017
30016_dirs_2017-02-21_cce660d1-4951-414d-bcf1-5c17f8dc9748.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2017-02-16
Reporting Person: END WILLIAM T (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-16 | Common Stock | S | 5000 | $141.7068 | Disposed | 50256 | Direct |
Footnotes
F1: Represents the weighted average sales price of the shares sold ranging from a low of $141.6166 to a high of $141.8165 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26